Research & Education

2nd Webinar: IASLC Lung Cancer Grand Rounds Series - Management of Patients with ALK Positive NSCLC

February 10, 2014

The second webinar in the series, Management of ALK Positive NSCLC took place on February 10, 2014. The recording is available below.  Ramaswamy Govindan, MD moderated the session, and Alice Shaw, MD,PhD  briefly reviewed ALK Positive NSCLC and presented several patient case studies for discussion.

Alice Shaw, MD, PhD 

Associate Professor of Medicine, Massachusetts General Hospital and Harvard Medical School

Ramaswamy Govindan, MD 

Co-Director, Section of Medical Oncology

Professor of Medicine, Division of Oncology

Washington University School of Medicine

This CME  live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.

The second webinar in the series, Management of ALK Positive NSCLC will take place on February 10, 2014.  Ramaswamy Govindan, MD will moderate the session,  and Alice Shaw, MD, PhD will briefly review ALK Positive NSCLC, discuss resistance to ALK inhibitors, and present several patient case studies for discussion.

CME INFO:

Fourteen grand rounds webinars in total will be held in 2014 as part of this new educational series, from January-December 2014. Participants who complete a pre-and post-test along with an evaluation will receive 1 AMA PRA Category 1 CreditTM for each completed webinar.

This series is supported in part by unrestricted educational grants provided by Bristol-Myers Squibb Co., Celgene and Genentech